Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Occluded Artery Trial (OAT) [Phase 3]
Phase 3 Occluded Artery Trial (OAT) has completed. Results were posted in 2013.
-
FDA label_change · 2013-02-05FDA Approved: INDAPAMIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for indapamide from Actavis Pharma, resulting in labeling changes for the product.
-
FDA approval · 2013-02-05FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. (ANDA 086513).
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not
A completed study evaluated the risk of coronary heart disease and heart failure in prostate cancer patients treated with Casodex (bicalutam…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of levosimendan in critically ill children with severe acute heart failure was ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. [Phase 3]
Phase 3 IMMEDIATE trial evaluating out-of-hospital glucose-insulin-potassium therapy for acute cardiovascular conditions has completed; resu…
-
FDA approval · 2013-01-28FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc. (generic) under an Abbreviated New…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function" [Phase 2]
This Phase 2 clinical trial from the University of Aarhus studied the effect of modulating free fatty acids on left ventricular function in …
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure [Phase 2, Phase 3]
This clinical trial update reports completion of Phase 2/3 testing of bypass surgery with CD133-positive marrow cell injections for ischemic…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat [Phase 4]
Phase 4 clinical trial evaluating Shensong Yangxin Capsule for heart failure complicated by premature ventricular contractions (PVCs).
-
FDA approval · 2013-01-07FDA Approved: TORSEMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' torsemide supplemental application (ANDA 079234), resulting in an approved updated torsemide product un…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters
The clinical trial evaluating whether abnormal REVEAL parameters can predict heart failure readmissions has been terminated, per the update.
-
CLINICAL_TRIALS research · 2013-01-03Clinical Trial Update: Registry of Cardiovascular Disease Patients
This entry describes a cardiovascular disease patient registry study (NCT01759225) sponsored by Maccabi Healthcare Services in Israel, curre…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Efficacy of a Home-Based Exercise Program for Heart Failure [NA]
A clinical trial evaluating a home-based exercise program for heart failure was terminated; the snippet does not include efficacy results.
-
CLINICAL_TRIALS research · 2012-12-27Clinical Trial Update: IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
This is a completed registry study (IMPROVE HF) evaluating the use of evidence-based heart failure therapies in outpatient settings, with re…
-
CLINICAL_TRIALS research · 2012-12-24Clinical Trial Update: The Prevalence of Thiamin Deficiency in Ambulatory Patients With Heart Failure
This clinical trial update reports on the prevalence of thiamin deficiency in ambulatory patients with heart failure.
-
CLINICAL_TRIALS research · 2012-12-24Clinical Trial Update: Brain Function and Perfusion in Patients With Heart Failure
This clinical trial update reports on brain function and cerebral perfusion in patients with heart failure, including those with dilated car…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal [NA]
A completed clinical trial comparing echocardiography-guided AV delay optimization to SonR signal–based optimization in patients with heart …
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure [Phase 1, Phase 2]
Phase 1/2 trial evaluating brain natriuretic peptide as a cardiac hormone replacement in heart failure and cardiomyopathy has completed and …
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites [NA]
Completed clinical trial evaluating whether B-type natriuretic peptide can aid diagnosis of heart failure-related ascites in patients with h…
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for Losartan Potassium 25 mg by Strides Pharma Science Limited, authorizing the generic product fo…
-
FDA approval · 2012-12-17FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Quinapril from Cipla USA Inc., marking an additional regulatory action for this ACE inhibito…
-
CLINICAL_TRIALS withdrawal · 2012-12-17Clinical Trial Update: Preoperative Levosimendan and Heart Failure [Phase 4]
A Phase 4 trial evaluating preoperative levosimendan in patients with heart failure undergoing hip fracture surgery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy [Phase 3]
Phase 3 trial evaluating adding nesiritide (Natrecor) to standard-care therapy versus placebo in patients with worsening congestive heart fa…